The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Press > Sopharma AD has acquired a total of 68% of the capital of Veta Pharma AD
Sopharma AD has acquired a total of 68% of the capital of Veta Pharma AD
11 November 2016
Sopharma AD hereby notifies that following a decision of the Board of directors as of the moment Sopharma AD has acquired a total of 68% of the capital of Veta Pharma AD.